A novel fibroblast growth factor receptor 1 inhibitor protects against cartilage degradation in a murine model of osteoarthritis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Xu, Wei ^a   Xie, Yangli ^a   Wang, Quan ^a   Wang, Xiaofeng ^a   Luo, Fengtao ^a   Zhou, Siru ^a   Wang, Zuqiang ^a   Huang, Junlan ^a   Tan, Qiaoyan ^a   Jin, Min ^a   Qi, Huabing ^a   Tang, Junzhou ^a   Chen, Liang ^a   Du, Xiaolan ^a   Zhao, Chengguang ^b   Liang, Guang ^b   Chen, Lin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FGFR1 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; G141 COMPOUND; PROTEIN KINASE INHIBITOR; SPIRO COMPOUND;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; ARTICULAR CARTILAGE; CHONDROCYTE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; METABOLISM; MOUSE; OSTEOARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CARTILAGE, ARTICULAR; CHONDROCYTES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INJECTIONS, INTRA-ARTICULAR; MICE; OSTEOARTHRITIS; PROTEIN KINASE INHIBITORS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SIGNAL TRANSDUCTION; SPIRO COMPOUNDS;

EID: 84962685860     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24042     Document Type: Article

References (39)

1. Bijlsma, J. W., Berenbaum, F. & Lafeber, F. P. Osteoarthritis: an update with relevance for clinical practice. Lancet 377, 2115-2126, doi: 10. 1016/S0140-6736(11)60243-2 (2011).
2. Ma, B., van Blitterswijk, C. A. & Karperien, M. A Wnt/beta-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis Rheum 64, 2589-2600, doi: 10. 1002/art. 34425 (2012).
3. Zhang, Y. et al. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. Ann Rheum Dis 74, 1432-1440, doi: 10. 1136/annrheumdis-2013-204599 (2015).
4. Lin, A. C. et al. Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 15, 1421-1425, doi: 10. 1038/ nm. 2055 (2009).
5. Ellman, M. B. et al. Fibroblast growth factor control of cartilage homeostasis. J Cell Biochem 114, 735-742, doi: 10. 1002/jcb. 24418 (2013).
6. Vincent, T. L. Explaining the Fibroblast Growth Factor Paradox in Osteoarthritis: Lessons From Conditional Knockout Mice. Arthritis Rheum 64, 3835-3838, doi: 10. 1002/Art. 34648 (2012).
7. Valverde-Franco, G. et al. Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice. Hum Mol Genet 15, 1783-1792, doi: 10. 1093/Hmg/Ddl100 (2006).
8. Weng, T. et al. Genetic inhibition of fibroblast growth factor receptor 1 in knee cartilage attenuates the degeneration of articular cartilage in adult mice. Arthritis Rheum 64, 3982-3992, doi: 10. 1002/art. 34645 (2012).
9. Yan, D. et al. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes. Arthritis Res Ther 13, doi: 10. 1186/Ar3441 (2011).
10. Wu, J. et al. Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer. BMC cancer 15, 276, doi: 10. 1186/s12885-015-1307-9 (2015).
11. Wang, Y. et al. Discovery and identification of new non-ATP competitive FGFR1 inhibitors with therapeutic potential on non-smallcell lung cancer. Cancer Lett 344, 82-89, doi: 10. 1016/j. canlet. 2013. 10. 016 (2014).
12. Yan, D., Chen, D. & Im, H. J. Fibroblast growth factor-2 promotes catabolism via FGFR1-Ras-Raf-MEK1/2-ERK1/2 axis that coordinates with the PKCdelta pathway in human articular chondrocytes. J Cell Biochem 113, 2856-2865, doi: 10. 1002/jcb. 24160 (2012).
13. Sharif, M., Whitehouse, A., Sharman, P., Perry, M. & Adams, M. Increased apoptosis in human osteoarthritic cartilage corresponds to reduced cell density and expression of caspase-3. Arthritis Rheum 50, 507-515, doi: 10. 1002/art. 20020 (2004).
14. Weng, T. et al. Loss of Vhl in cartilage accelerated the progression of age-associated and surgically induced murine osteoarthritis. Osteoarthritis Cartilage 22, 1197-1205, doi: 10. 1016/j. joca. 2014. 06. 031 (2014).
15. Davidson, D. et al. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem 280, 20509-20515, doi: 10. 1074/jbc. M410148200 (2005).
16. Moore, E. E. et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 13, 623-631, doi: 10. 1016/j. joca. 2005. 03. 003 (2005).
17. Uchii, M. et al. Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis. Arthritis Res Ther 10, R90, doi: 10. 1186/ ar2474 (2008).
18. Wang, S. X., Bendele, A. M. & Moore, E. M. The Chondroprotective Effect of Fgf9 in an Experiment Model of Osteoarthritis. Osteoarthritis Cartilage 20, S40-S41 (2012).
19. Loeser, R. F., Chubinskaya, S., Pacione, C. & Im, H. J. Basic fibroblast growth factor inhibits the anabolic activity of insulin-like growth factor 1 and osteogenic protein 1 in adult human articular chondrocytes. Arthritis Rheum 52, 3910-3917, doi: 10. 1002/ art. 21472 (2005).
20. Yan, D. et al. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes. Arthritis Res Ther 13, doi: 10. 1186/ar3441 (2011).
21. Chia, S. L. et al. Fibroblast Growth Factor 2 Is an Intrinsic Chondroprotective Agent That Suppresses ADAMTS-5 and Delays Cartilage Degradation in Murine Osteoarthritis. Arthritis Rheum 60, 2019-2027, doi: 10. 1002/Art. 24654 (2009).
22. Ellman, M. B., An, H. S., Muddasani, P. & Im, H. J. Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene 420, 82-89, doi: 10. 1016/j. gene. 2008. 04. 019 (2008).
23. Muddasani, P., Norman, J. C., Ellman, M., van Wijnen, A. J. & Im, H.-J. Basic fibroblast growth factor activates the MAPK and NF kappa B pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes. J Biol Chem 282, 31409-31421, doi: 10. 1074/jbc. M706508200 (2007).
24. Pelletier, J. P. et al. In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes. Arthritis Rheum 48, 1582-1593, doi: 10. 1002/art. 11014 (2003).
25. Radons, J., Bosserhoff, A. K., Grassel, S., Falk, W. & Schubert, T. E. p38MAPK mediates IL-1-induced down-regulation of aggrecan gene expression in human chondrocytes. Int J Mol Med 17, 661-668 (2006).
26. van der Kraan, P. M. & van den Berg, W. B. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage 20, 223-232, doi: 10. 1016/j. joca. 2011. 12. 003 (2012).
27. Takayama, K. et al. Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis. Arthritis Res Ther 16, 482, doi: 10. 1186/s13075-014-0482-4 (2014).
28. Lawson, K. A. et al. Mesenchyme-specific knockout of ESET histone methyltransferase causes ectopic hypertrophy and terminal differentiation of articular chondrocytes. J Biol Chem 288, 32119-32125, doi: 10. 1074/jbc. M113. 473827 (2013).
29. DLima, D., Hermida, J., Hashimoto, S., Colwell, C. & Lotz, M. Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. Arthritis Rheum 54, 1814-1821, doi: 10. 1002/art. 21874 (2006).
30. Ornitz, D. M. & Marie, P. J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16, 1446-1465 (2002).
31. Legeai-Mallet, L., Benoist-Lasselin, C., Delezoide, A. L., Munnich, A. & Bonaventure, J. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J Biol Chem 273, 13007-13014 (1998).
32. Sahni, M., Raz, R., Coffin, J. D., Levy, D. & Basilico, C. STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development 128, 2119-2129 (2001).
33. Gigout, A., Lindemann, S. & Guehring, H. Sprifermin (Rhfgf18) Has an Anabolic Effect on Human Osteoarthritic Chondrocytes Involving Fgfr3 and Erk1/2 but Not P38 Alpha and Jnks. Osteoarthritis Cartilage 22, S164-S164 (2014).
34. Liang, G. et al. Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcumin. Bioorg Med Chem Lett 18, 1525-1529 (2008).
35. Li, X. et al. Species-specific biological effects of FGF-2 in articular cartilage: implication for distinct roles within the FGF receptor family. J Cell Biochem 113, 2532-2542, doi: 10. 1002/jcb. 24129 (2012).
36. Stanton, H. et al. Investigating ADAMTS-mediated aggrecanolysis in mouse cartilage. Nat Protoc 6, 388-404, doi: 10. 1038/ nprot. 2010. 179 (2011).
37. Minashima, T., Zhang, Y., Lee, Y. & Kirsch, T. Lithium protects against cartilage degradation in osteoarthritis. Arthritis Rheum 66, 1228-1236, doi: 10. 1002/art. 38373 (2014).
38. Glasson, S. S., Blanchet, T. J. & Morris, E. A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 15, 1061-1069, doi: 10. 1016/j. joca. 2007. 03. 006 (2007).
39. Glasson, S. S., Chambers, M. G., Van Den Berg, W. B. & Little, C. B. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 18 Suppl 3, S17-23, doi: 10. 1016/j. joca. 2010. 05. 025 (2010).